Intas Pharmaceuticals names new leaders in Gene Therapy, IT, Quality Control, learning and development Ruchika Sharma24 April 2025 5:34 PM ISTIntas Pharmaceuticals has announced a series of leadership appointments across several core areas, including gene therapy, information technology,...
Intas Pharma appoints Sarang Pande as Vice President - Digital Manufacturing & Industry Automation Ruchika Sharma17 April 2025 12:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Sarang Pande as Vice President - Digital Manufacturing & Industry Automation.In...
Intas Pharma appoints Parthiv Mehta as Vice President - Rest of Africa & International Fertility Ruchika Sharma9 April 2025 4:13 PM ISTAhmedabad: Intas Pharma has announced the appointment of Parthiv Mehta as the new Vice President - Rest of Africa & International...
Intas Pharma to acquire Udenyca business from Coherus BioSciences Ruchika Sharma4 Dec 2024 11:55 AM ISTRaleigh: Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology,...
Intas Pharma, Henlius receive positive CHMP opinion for Hetronifly in European markets as first line treatment for adult patients with Extensive-Stage Small Cell Lung Cancer Ruchika Sharma26 Sept 2024 11:00 AM ISTAhmedabad: Intas Pharmaceuticals Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
CDSCO Panel grants Intas Package Insert update for Pegfilgrastim solution for injection 6mg/0.6mL vial and PFS Dr. Divya Colin5 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Center Drug Standard Control Organisation (CDSCO) has approved drug major Intas...
Intas Pharma Gets CDSCO Panel Nod to Study anti-cancer Drug Lipid Based Cabazitaxel Dr. Divya Colin1 Feb 2024 6:00 PM ISTNew Delhi: Citing that the firm should include an adequate number of government hospital trial sites, the Subject Expert Committee (SEC) functional...
Intas Pharma gets exclusive rights to commercialize Etanercept biosimilars in more than 150 countries across globe Ruchika Sharma25 Dec 2023 11:30 AM ISTAhmedabad: Intas Pharmaceuticals Ltd., a multinational pharmaceutical company, has announced a strategic exclusive licensing agreement with...
Intas Pharma gets USFDA warning letter due to manufacturing lapses at Ahmedabad plant Ruchika Sharma11 Dec 2023 11:30 AM IST"Repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate," USFDA said.
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Intas Pharma Sanand plant gets USFDA warning letter Ruchika Sharma7 Aug 2023 12:30 PM IST"Our investigators observed plastic bags filled with torn and discarded original CGMP documents in your quality control scrap area under a stairwell,...
Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
